gadoterate meglumine

In shortageOrange BookUNIISPLATC V08CA02

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerSlate Run Pharmaceuticals, LLC

CountryUS (United States)

ATC codeV08CA02

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 2

ndc11
7043612356
6 VIAL in 1 CARTON (70436-123-56) / 100 mL in 1 VIAL (70436-123-40)
ndc11
7043612380
1 VIAL in 1 CARTON (70436-123-80) / 100 mL in 1 VIAL (70436-123-40)

Annotations

UNII (FDA Substance ID)

L0ND3981AG

GADOTERATE MEGLUMINE

RxCUI 1421151

Orange Book

A218073

APAPAPAPAP

DailyMed SPL labels

1 version tracked

FDA shortage

Currently in shortage

Gadoterate Meglumine Injection

Raw payload (JSON)

{
  "unii": {
    "unii": "L0ND3981AG",
    "rxcui": "1421151",
    "inchikey": "RYHQMKVRYNEBNJ-BMWGJIJESA-K",
    "display_name": "GADOTERATE MEGLUMINE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "spl_meta": {
    "fbebe7f2-a0c2-4fd5-b421-8fbcbaf46709": {
      "match": "brand_token",
      "title": "GADOTERATE MEGLUMINE INJECTION [FRESENIUS KABI USA, LLC]",
      "spl_version": "2",
      "published_date": "2025-11-27"
    }
  },
  "productid": "70436-123_32f1564f-e077-5f10-e063-6394a90afd33",
  "productndc": "70436-123",
  "dosage_form": "INJECTION",
  "orange_book": {
    "appl_no": "218073",
    "products": [
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "1.8845GM/5ML (376.9MG/ML)",
        "product_no": "001",
        "approval_date": "Jun 17, 2024"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "3.769GM/10ML (376.9MG/ML)",
        "product_no": "002",
        "approval_date": "Jun 17, 2024"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "5.6535GM/15ML (376.9MG/ML)",
        "product_no": "003",
        "approval_date": "Jun 17, 2024"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "7.538GM/20ML (376.9MG/ML)",
        "product_no": "004",
        "approval_date": "Jun 17, 2024"
      },
      {
        "rs": false,
        "rld": false,
        "te_code": "AP",
        "strength": "37.69GM/100ML (376.9MG/ML)",
        "product_no": "005",
        "approval_date": "Jun 17, 2024"
      }
    ],
    "appl_type": "A"
  },
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "GADOTERATE MEGLUMINE",
  "shortage_reason": "Gadoterate Meglumine Injection",
  "shortage_status": "current",
  "proprietary_name": "gadoterate meglumine",
  "active_ingred_unit": "mg/mL",
  "application_number": "ANDA218073",
  "marketing_category": "ANDA",
  "nonproprietary_name": "gadoterate meglumine",
  "start_marketing_date": "20240628",
  "active_numerator_strength": "376.9"
}

Related drugs

Other records sharing ATC code V08CA02.

Access this data programmatically

Query gadoterate meglumine and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs